Literature DB >> 20709010

Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7.

Jafar Amani1, Ali Hatef Salmanian, Sima Rafati, Seyed Latif Mousavi.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) comprise an important group of enteric pathogens causing hemorrhagic colitis and hemolytic uremic syndrome. These bacteria need EspA (E) as a conduct for Tir (T) delivery to the host cell and surface arrayed intimin (I) which docks the bacterium to the translocated Tir. This phenomenon leads to attaching and effacing (A/E) lesions. A trivalent recombinant protein called rEIT composed of immunologically important portions of EspA, Intimin and Tir was constructed as a candidate vaccine. For high-level expression, the EIT gene was synthesized with codon bias of E. coli. The immunization was conducted in mice with purified rEIT. The results showed that this chimeric protein induced strong humoral response as well as protection against live challenges using EHEC.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709010     DOI: 10.1016/j.vaccine.2010.07.061

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

Review 1.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli.

Authors:  David A Montero; Felipe Del Canto; Juan C Salazar; Sandra Céspedes; Leandro Cádiz; Mauricio Arenas-Salinas; José Reyes; Ángel Oñate; Roberto M Vidal
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

3.  Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer.

Authors:  Elaheh Gheybi; Jafar Amani; Ali Hatef Salmanian; Farhad Mashayekhi; Samaneh Khodi
Journal:  Tumour Biol       Date:  2014-08-16

4.  A DNA vaccine against Escherichia coli O157:H7.

Authors:  Kowsar Shariati Mehr; Seyed Latif Mousavi; Iraj Rasooli; Jafar Amani; Masoumeh Rajabi
Journal:  Iran Biomed J       Date:  2012

Review 5.  Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection.

Authors:  Victor A Garcia-Angulo; Anjana Kalita; Alfredo G Torres
Journal:  Vaccine       Date:  2013-05-22       Impact factor: 3.641

6.  Intranasal co-administration of recombinant active fragment of Zonula occludens toxin and truncated recombinant EspB triggers potent systemic, mucosal immune responses and reduces span of E. coli O157:H7 fecal shedding in BALB/c mice.

Authors:  Aravind Shekar; Shylaja Ramlal; Joseph Kingston Jeyabalaji; Murali Harishchandra Sripathy
Journal:  Med Microbiol Immunol       Date:  2018-09-12       Impact factor: 3.402

7.  Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7.

Authors:  Tahere Doavi; Seyed Latif Mousavi; Mehdi Kamali; Jafar Amani; Mahdi Fasihi Ramandi
Journal:  Iran Biomed J       Date:  2016-01-02

8.  Antibodies Directed against Shiga-Toxin Producing Escherichia coli Serotype O103 Type III Secreted Proteins Block Adherence of Heterologous STEC Serotypes to HEp-2 Cells.

Authors:  Taseen S Desin; Hugh G Townsend; Andrew A Potter
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

9.  EspA-Intimin chimeric protein, a candidate vaccine against Escherichia coli O157:H7.

Authors:  Hamid Sedighian Rad; Seyed Latif Mousavi; Iraj Rasooli; Jafar Amani; Moohamad Reza Jalali Nadooshan
Journal:  Iran J Microbiol       Date:  2013-09

10.  Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice.

Authors:  Zahra Sadat Hosseini; Jafar Amani; Fahimeh Baghbani Arani; Shahram Nazarian; Mohammad Javad Motamedi; Fatemeh Shafighian
Journal:  Clin Exp Vaccine Res       Date:  2018-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.